1. In this secondary analysis of a randomized, controlled trial, 26.8% of community-acquired pneumonia patients who received 3 days of ...
1. The administration of the probiotic Lactobacillus rhamnosus GG resulted in no significant difference compared to placebo in the development ...
1. Retrospective analysis of hospital records showed decreased hospital admission rates for non-COVID-19 diseases in Denmark since the first lockdown. ...
1. Hospitalized COVID-19 patients receiving high-dose methylprednisolone followed by oral prednisone had improved clinical outcomes compared to patients receiving dexamethasone. ...
1. Cure at 15 days occurred in 77% of patients in the placebo (3-day therapy) group compared to 68% of ...
1. Five-day treatment of community-acquired pneumonia in children was comparable to standard, 10-day treatment. Evidence Rating Level: 2 (Good) Community-acquired pneumonia ...
1. Tocilizumab reduced the need for mechanical ventilation and lowered death outcomes in patients infected with severe acute respiratory syndrome ...
1. The most common complications associated with COVID-19 with high absolute risk were viral pneumonia, respiratory failure, acute kidney failure, ...
1. In this noninferiority study, children who received placebo for pneumonia with tachypnea had a higher incidence of treatment failure ...
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.
